Publication | Closed Access

Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity

ImmunologyPathologyFatty Liver DiseaseInsulin SignalingObesityMetabolic SyndromeMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseHepatology FibrosisHealth SciencesFibrosisMetabolic Associated SteatohepatitisBiochemistryLiver PhysiologyHepatology InflammationHepatologySignificant Liver FibrosisDiabetesLiver DiseaseMedicine